BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 1360341)

  • 1. The role of T-cell subsets in the response to anti-CD3 monoclonal antibodies.
    Finck BK; Yung CM; Carteron NL; Wofsy D
    Clin Immunol Immunopathol; 1992 Dec; 65(3):234-41. PubMed ID: 1360341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5 costimulation up-regulates the signaling to extracellular signal-regulated kinase activation in CD4+CD8+ thymocytes and supports their differentiation to the CD4 lineage.
    Zhou XY; Yashiro-Ohtani Y; Toyo-Oka K; Park CS; Tai XG; Hamaoka T; Fujiwara H
    J Immunol; 2000 Feb; 164(3):1260-8. PubMed ID: 10640739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
    Woodle ES; Hussein S; Bluestone JA
    Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
    Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
    J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4.
    Zlotnik A; Godfrey DI; Fischer M; Suda T
    J Immunol; 1992 Aug; 149(4):1211-5. PubMed ID: 1386860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.
    Koyasu S
    J Exp Med; 1994 Jun; 179(6):1957-72. PubMed ID: 8195719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entry of CD4-CD8- immature thymocytes into the CD4/CD8 developmental pathway is controlled by tyrosine kinase signals that can be provided through TCR components.
    Takahama Y; Hasegawa T; Itohara S; Ball EL; Sheard MA; Hashimoto Y
    Int Immunol; 1994 Oct; 6(10):1505-14. PubMed ID: 7826942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-frequency activation of single CD4+ and CD8+ T cells to proliferate and secrete cytokines using anti-receptor antibodies and IL-2(1).
    Maraskovsky E; Pech MH; Kelso A
    Int Immunol; 1991 Mar; 3(3):255-64. PubMed ID: 1675587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo treatment of class II MHC-deficient mice with anti-TCR antibody restores the generation of circulating CD4 T cells and optimal architecture of thymic medulla.
    Nasreen M; Ueno T; Saito F; Takahama Y
    J Immunol; 2003 Oct; 171(7):3394-400. PubMed ID: 14500633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes.
    Nishimura H; Agata Y; Kawasaki A; Sato M; Imamura S; Minato N; Yagita H; Nakano T; Honjo T
    Int Immunol; 1996 May; 8(5):773-80. PubMed ID: 8671666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells.
    Staats HF; Oakes JE; Lausch RN
    J Virol; 1991 Nov; 65(11):6008-14. PubMed ID: 1920624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4-CD8- thymocytes from MRL-lpr/lpr mice exhibit abnormal proportions of alpha beta- and gamma delta-TCR+ cells and demonstrate defective responsiveness when activated through the TCR.
    Kakkanaiah VN; Nagarkatti M; Bluestone JA; Nagarkatti PS
    Cell Immunol; 1991 Oct; 137(2):269-82. PubMed ID: 1832583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LD1: a CD4-CD8- TCR alpha beta/CD3+ peripheral T cell line with helper function for B lymphocytes.
    Pelkonen J; Palacios R
    Int Immunol; 1990; 2(6):555-62. PubMed ID: 2150761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of thymocyte development through CD3. II. Expression of T cell receptor beta CD3 epsilon and maturation to the CD4+8+ stage are highly correlated in individual thymocytes.
    Levelt CN; Carsetti R; Eichmann K
    J Exp Med; 1993 Dec; 178(6):1867-75. PubMed ID: 7504052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of thymocyte development through CD3. I. Timepoint of ligation of CD3 epsilon determines clonal deletion or induction of developmental program.
    Levelt CN; Ehrfeld A; Eichmann K
    J Exp Med; 1993 Mar; 177(3):707-16. PubMed ID: 8382254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
    Schneider MK; Grönvik KO
    Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinetics of T cell antigen receptor expression by subgroups of CD4+8+ thymocytes: delineation of CD4+8+3(2+) thymocytes as post-selection intermediates leading to mature T cells.
    Shortman K; Vremec D; Egerton M
    J Exp Med; 1991 Feb; 173(2):323-32. PubMed ID: 1824855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
    Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
    J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.